Sign in

CIK 0001631574

  • Large accelerated filer

Wave Life Sciences, Inc.

Sign in to watch
Ticker
WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2900
Business address
733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
Former names
Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
  1. 4 Grant or award Director acquired 12,700 shares (grant or award)
  2. 4 Planned sale Director sold 9,670 shares at $8.81 ($85,193)
  3. 4 Grant or award Director acquired 12,700 shares (grant or award)
  4. 4 Grant or award Director acquired 12,700 shares (grant or award)
  5. 4 Planned sale Director sold 4,872 shares at $8.75 ($42,630)
  6. 4 Planned sale Director sold 1,127 shares at $8.75 ($9,861)
  7. 4 Planned sale Director sold 30,000 shares at $6.95 ($208,500)
  8. 4 Planned sale Director sold 10,500 shares at $9.77 ($102,575)
  9. 4 Planned sale President and CEO sold 169,025 shares at $9.57 ($1,617,569)
  10. 4 Option exercise Director acquired 266,402 shares (option exercise)
  11. 4 Option exercise See Remarks acquired 91,754 shares (option exercise)
  12. 4 Grant or award Chief Financial Officer acquired 42,000 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 121,000 shares (grant or award)
  14. 4 Grant or award See Remarks acquired 25,000 shares (grant or award)
  15. 4 Grant or award See Remarks acquired 37,000 shares (grant or award)
  16. 4 Option exercise See Remarks acquired 46,000 shares (option exercise)
  17. 4 Planned sale President and CEO sold 50,000 shares at $15.00 ($750,000)
  18. 4 Planned sale President and CEO sold 51,234 shares at $14.32 ($733,671)
  19. 4 Planned sale See Remarks sold 36,000 shares at $16.00 ($576,000)
  20. 4 Planned sale See Remarks sold 208,836 shares at an average $13.67 ($2,855,051)

Page 3 of 14 · 274 filings